We produce active plant ingredients in a
sustainable way

Reducing economic and environmental costs with in vitro molecular biology techniques


Increasing x20 the amount of active ingredients generated per square meter and
euro invested


Enhancing the quality of raw material by producing it under sterile conditions and free of unwanted foreign matter


Bringing sustainability back to the pharmaceutical industry by reducing

x50 the use of H2O
x10 the amount of energy
x5 atmospheric CO2 emissions

Substances produced with innovative technology



Selecting plant genetics with high CO2 absorption and percentage of active

Propagating them through in vitro glandular organogenesis, i.e. by growing only substance-producing glands under sterile conditions

Automating the process with sensorized bioreactors which control and adapt the
growth conditions based on the needs of the product

We grow in environmentally friendly phytotrons

Taking advantage of natural energy resources (light, temperature, humidity).
Maximizing the use of the square meter by being stackable with a beehive-like
Using IoT and AI to prevent product contamination

Kanara is a clear example of where the industry should be heading, both in terms of narrative and product. A wave of innovation driven by startups with talented teams, striving to come up with innovative solutions that are less harmful to humans and more sustainable for the planet.

- Ángel Gutiérrez - CEO of Catalyst


Leopoldo Machado

CEO & Co-Founder

Eduardo W. Jørgensen

Scientific Affairs & Co-Founder


renowned advisors
in the Pharma, Legal, Commercial and
Agrotech industries.

Jorge Gutierrez

CTO & Co-Founder

Ana Arencibia

Head of Business Development

Raul Clemente

COO & Co-Founder


Head of Biotechnology

Sara Gonzalez

Research Associate